Mad Money w/ Jim Cramer 1/16/25

Summary

Mad Money with Jim Cramer – Episode Summary (January 16, 2025)

Release Date: January 17, 2025

---

1. Economic and Political Commentary

Jim Cramer opens the episode by delving into the impact of the Biden administration's policies on the economy and Wall Street. He discusses the sentiment among CEOs who believe that the administration's approach has been antagonistic towards big business, leading to regulatory challenges and stifled growth in various industries.

• Impact on Big Pharma: Cramer highlights the Inflation Reduction Act (IRA) and its provisions allowing Medicare to negotiate drug prices. He notes CEOs' frustrations with “the endless parade of new regulations stifling important industries” (04:45).

• Semiconductor Sector: He contrasts the IRA's challenges with the positive effects of the Chips and Science Act, though he criticizes the unequal distribution of subsidies, particularly favoring Intel (06:30).

• Fossil Fuels vs. Renewables: Cramer discusses how oil companies have managed to prosper despite the administration's skepticism towards fossil fuels, attributing their success to a lack of dialogue with the President (07:15).

• Banking Industry: The bank sector, despite regulatory pressures, has seen significant profitability. Cramer emphasizes the need for a balanced relationship between the government and businesses to foster growth (09:00).

Notable Quote:

"Mad Money starts now. Hey, I'm Cramer. Welcome to Mad Money. My mission is simple: to make you money." (01:21)

2. Interview with Dr. Vlad Schor – CEO of Biohaven

Cramer sits down with Dr. Vlad Schor, Chairman and CEO of Biohaven Ltd., to discuss the company's advancements and future pipeline. Biohaven, known for its successful migraine drug sold to Pfizer, is expanding into treatments for OCD, epilepsy, bipolar disorder, obesity, and oncology.

• Innovative Treatments: Dr. Schor highlights Biohaven's unique approach to treating mania and epilepsy by targeting the KV7 ion channel, aiming to reduce side effects commonly associated with older medications (16:24).

• Precision Immunology: The company is pioneering in precision immunology, inspired by precision oncology, to develop targeted therapies that minimize impact on healthy immune functions (17:01).

• Future Prospects: Dr. Schor emphasizes the potential of their new therapies to provide more effective and less debilitating treatments for various neurological conditions (19:14).

Notable Quote:

"We're looking at some innovative approaches, new mechanisms that no one's ever explored today. And we have to do that for patients because when you look at our older drugs, they're indirectly hitting these diseases and frankly, they're not good enough for patients." – Dr. Vlad Schor (15:51)

3. Interview with Brian Jordan – CEO of First Horizon

Cramer discusses the performance and outlook of regional banks with Brian Jordan, Chairman and CEO of First Horizon. Despite a slight revenue miss, First Horizon has shown resilience with strong credit quality and strategic portfolio management.

• Economic Optimism: Jordan expresses confidence in the Southeast region's economic growth, supported by favorable demographic trends and business-friendly policies (23:28).

• Interest Rates Outlook: He adopts a cautious stance on future rate cuts, anticipating minimal adjustments unless significant economic shifts occur (24:58).

• Regulatory Environment: Jordan advocates for tailored regulations based on the size and systemic importance of financial institutions, suggesting that smaller banks like First Horizon face different challenges compared to giants like JPMorgan (25:35).

Notable Quote:

"Our charge-offs have been very contained. We feel good about our credit performance year over year – we're down about 10 basis points. So that really goes to the quality of our underwriting." – Brian Jordan (23:47)

4. Interview with Todd McKinnon – CEO of Okta

In a conversation about cybersecurity, Todd McKinnon, Co-founder and CEO of Okta, discusses the implications of the Biden administration's executive order on U.S. cybersecurity standards and its effects on the industry.

• Identity Verification Importance: McKinnon underscores the critical role of identity verification in preventing security breaches, noting that 80% of cyberattacks involve compromised identities (32:48).

• Government Partnerships: Okta's strong relationships with federal agencies, including the Department of Defense, position the company well to benefit from increased cybersecurity investments (31:56).

• Future of Identity Security: McKinnon emphasizes the necessity of independent and neutral identity platforms to provide flexibility and robust security, especially as AI technologies evolve (35:43).

Notable Quote:

"We're trying to lead the fight against these identity-based attacks. If we can solve these, we can address 80% of security breaches, which is a huge progress to make." – Todd McKinnon (32:48)

5. Callers' Questions and Responses

The episode features several callers seeking Jim Cramer's advice on various stocks:

• Rizwan from Texas: Seeks advice on Disney (DIS) amidst recent local fires. Cramer advises buying Disney, citing its resilience and strong franchise (09:01).

• Caller on Palantir (PLTR): Requests guidance on holding versus selling shares. Cramer recommends holding and buying back if prices drop, praising Palantir's data analysis capabilities (09:26).

• Trey from Texas: Asks about VF Corp (VFC) amidst personal financial strain. Cramer humorously suggests betting on VF Corp to save his marriage and anticipates the stock will rise (10:46).

• Aaron from Rhode Island: Inquires about Amazon (AMZN) performance. Cramer maintains a long-term bullish stance on Amazon, advocating for continued investment (40:06).

Notable Quote:

"When Jim Cramer talks, I listen." – Caller recalling Jim's influence and success with Palantir (09:28)

6. Lightning Round

In the high-energy Lightning Round segment, Cramer answers rapid-fire questions from callers about various stocks:

• Best Buy (BBY): Despite past challenges, Cramer remains optimistic, urging holds due to its solid fundamentals and future potential (41:18).

• Berkshire Financial (BFS): Cramer endorses Berkshire for its strong execution and market presence, recommending it as a buy (42:09).

• Other Stocks: Cramer offers quick takes on Alignment Health Care and other companies, emphasizing due diligence and strategic holds or buys based on company performance (40:50).

Notable Quote:

"Stocks performed well during the Biden administration's tenure, at least in the aggregate. But was it in spite of his policies?" (01:21)

7. Semiconductor Industry Analysis

Cramer critiques recent U.S. government policies affecting the semiconductor industry, particularly the restrictions imposed on Nvidia's high-end chip sales to certain countries. He expresses frustration over the selective nature of these restrictions, arguing that they undermine the industry's global competitiveness.

• Nvidia Restrictions: Cramer deems the Biden administration's decision to limit high-end chip exports to countries like Israel, Mexico, Portugal, and Switzerland as arbitrary and counterproductive (48:16).

• Taiwan Semiconductor Manufacturing (TSMC): Despite strong orders from TSMC, Cramer observes that the stock remains undervalued, attributing this to regulatory uncertainties (48:16).

• Chinese Accusations: He discusses China's claims that the U.S. Chips and Science Act unfairly supports domestic semiconductor companies, highlighting the ongoing trade tensions (48:16).

Notable Quote:

"The whole new regime seems unnecessarily restrictive to me... Maybe we can salvage it, but maybe we can't." – Jim Cramer (48:16)

8. Closing Remarks

Cramer wraps up the episode by reiterating his bullish outlook on various sectors and stocks discussed throughout the show. He emphasizes the importance of strategic investments and staying informed to navigate the complexities of the current market landscape.

Notable Quote:

"Bull market summer. I promise to find it just for you right here on Mad Money." – Jim Cramer (48:16)

---

Conclusion

This episode of Mad Money with Jim Cramer offers a comprehensive analysis of the interplay between government policies and business performance, insightful interviews with industry leaders in biotech, banking, and cybersecurity, as well as actionable investment advice through caller interactions and the Lightning Round. Cramer's critiques of policy decisions, especially those affecting the semiconductor industry, provide viewers with a deeper understanding of the factors influencing market movements.

---

Note: All timestamps correspond to the transcript provided and are intended to reference key moments within the episode.

Transcript

[Jim Cramer]

Meet Venu on the NYSE American Symbol Venu Disrupting a multi billion dollar live music industry, Venu owns and operates upscale music venues, outdoor amphitheaters with seven revenue sources $166 million in assets Luxury suite sales of $77 million in 2024 $200 million expected in 2025 56% year over year Growth venue on the NYSE American.

[Narrator/Commercial Speaker]

Venu homes.com knows that when it comes to home shopping, it's never just about the house or condo. It's about the home. And what makes a home is more than just the house or property. It's the location and neighborhood. If you have kids, it's also schools, nearby, parks and transportation options. That's why homes.com goes above and beyond to bring home shoppers the in depth information they need to find the right home. And when I say in depth, I'm talking deep. Each listing features comprehensive information about the neighborhood, complete with a video guide. They also have details about local schools with test scores, state rankings and student to teacher ratio. They even have an agent directory with the sales history of each agent. So when it comes to finding a home, not just the house, this is everything you need to know, all in one place. Homes.com, we've done your homework.

[Jim Cramer]

My mission is simple to make you money. I'm here to level the playing field for all investors. Always a bull market somewhere. And I promise to help you find it. Mad Money starts now. Hey, I'm Kramer. Welcome to Mad Money. Welcome to Kramer. Bill. Make friends. I'm just trying to make you a little money. My job is not just entertain, but to put things in context and explain them. So call me 1-800-743-CBC. Tweet me at Jim Cramer. Has the economy blossomed because of the Biden administration or in spite of it? This is the question so many execs are debating and their answer is a resounding in spite of as the average is dip date with The Dow declining 68 points, SB shedding point to 1%, Nasdaq losing 0.89%. We need to parse the in spite of or the because of phrase because it could be very important to what's happening next on Wall street into your portfolio. Regular viewers know that I'm not a politics guy, but I'm also not deaf, although I've been accused of both. Usually when there's something controversial like the current administration's approach to big business, I expect the CEOs of this country to avoid talking about it like the Bubonic plague. But with the Biden administration almost over, they can't. They can talk as much as they want and they are. What a frustrated bunch. They really want to have my ear. When I was in California, where I met or talked to a dozen CEOs from a host of gigantic big industries, everyone brought it up. No one thought that business and the stock market did well the last four years because of the Biden team. Now, I pushed back a minute. I said, you can't have this kind of unemployment backdrop. You know, it's been very, very strong and an amazing stock market. If the White House is totally antagonistic, the business. Give me a break. Wrong, they said. Some of them called me delusional. Their discouragement was palpable. The tough tone for the White House toward business and the endless parade of new regulations stifling imputer, they said almost in unison. The agencies were cited over and over again for their overzealous attitudes. Let me describe what I heard. First, the Biden administration pushed through the Inflation Reduction act, known as the ira, which gave Medicare the right to negotiate prices for some expensive drugs, as well as other limits that should hurt profits for Big Pharma. It's absolutely true. This is not good for the drug companies. Now, this is when I have to tell you that I see both sides of the equation. I know drug prices are often too high. I know many other countries do, similar to what the Biden administration did. But this is mad money, not mad health care policy. From the perspective of your portfolio, you want a government with a thoughtful approach to business. You want give and take discussions between business and the President. Maybe Biden did and I just couldn't find the right CEOs. But then again, I spoke to almost every big drug company CEO. And the ones I didn't, you wouldn't recognize the names. Worse, at least if you're a shareholder, you would have hoped that Pharma and biotech CEOs actually sat down with the President for something. Anything. Just explain why the drug companies don't see themselves as the villains in our particularly expensive health care system. But they didn't talk to each other. Some of the CEOs believe the President just didn't like the optics. I wonder if Biden was meeting with anybody outside the administration because his team seemed committed to hiding the fact that he's not as sharp as he used to be. Either way, if you're a shareholder, it's easy to see why the drug stocks trade so cheaply. You never knew what was going to happen. From potentially hostile White House we know the inconsistency of the Biden administration toward the semiconductors to more on this later. For now, let me just say that the Chips and Science act did a huge amount for the semiconductor industry. I think it's great it did, but the subsidies weren't spread out and they gave a ridiculous amount of money to Intel, a company that to me is deeply troubled. We know oil prospered in spite of Biden because he's not a fan of fossil fuels. I pushed back on this one too, arguing that they couldn't have fared that poorly. The stocks have been pretty good. Again though, I heard that in spite of Biden and a new one, his naivete in part because again the President would not meet with industry leaders. There was no dialogue between fossil fuel execs and this president. He is the anti fossil fuel pro renewables president. Renewable projects proved to be expensive though and they're not just one part of the they're only a part of the energy mosaic. They can't take it over. The oil company CEOs that I know wanted to plead their case, play ball, but they never got a chance. Instead they got a kick in the teeth though almost one year ago when the President crushed the most viable portion of the complex, the liquefied natural gas market, by putting a pause on new export decisions pending environmental review. Get no dialogue. Again naivete because if you want to win the war in Ukraine, you need to give Europe a new non Russian source of gas. According to public documents though, President Biden never intended to lift the pause for the greatest blue collar jobs program available in maybe, well today could be in history. I don't know. It's huge by the way. These are huge private high pay projects. Totally dashed. Biden, they say also made unreasonable rules about where the you could drill rules that might not easily be overturned by President Trump. But the biggest despite of came from the banks. You know they all reported in the last few days I spoke to a whole host of bank CEOs and this group can't wait to give the President his hat, ask him what's the hurry and happily hold open the door. These financial CEOs couldn't resist taking some parting shots at the Biden team. Yet I talked about how much money they made under Biden. How big could it be? The issues though have more to do with tone. With respect, these industries weren't exactly in love with Obama administration, but I never heard anyone say any of these things about Obama when he was leaving office in the End Biden stocked key agencies with people who truly dislike big business and tried to block pretty much any merger. I came back and said I thought there were so many mergers in previous administrations like the airlines, that now we have tons of non competitive routes. But let me give you the in spite of here that the market, the banks went up in spite of. Rather than have a discussion between the parties, the agencies would simply sue. Again, no dialogue. They created an environment where few companies would want to go through the merger gauntlet. It had a very successful chilling effect on doing new deals, many of which would have made shareholders like you a great deal of money. The regulators acted harshly in the pendulum, which was too loose at the time of the minibank crisis two years ago, became way too punitive. There's that word again. Punitive. When the regulators would step in, one banker said that the regulator showed so little respect that he thought they just wanted to stifle his business. The bankers wanted some degree of transparency about the new regulations that intruded endlessly on what they were doing. They wanted some sense of the real capital levels that the government wanted to see. And they wanted a seat at the table when the President discussed business. Didn't happen. Then again, who knows if the President was discussing any of this stuff with anybody. For all we know, it was sadly a weekend at Bernie's White House. Several CEOs said that, look, maybe it didn't matter. Everything turned out to be just fine. Could have been better, of course. Maybe it will even be better with President elect Trump, but maybe it won't. Ultimately, I think that a President should develop a good relationship with the business community. They should talk. There should be dialogue. Biden was indeed needlessly antagonistic. I have that feeling after speaking with these people. Not to say that I'm all with them, but the antagonism was too palpable. The bottom line, if all that matters is who wins the next election, you could argue that this style didn't work. That business might have been able to help bring down inflation, which is what I think undid the Democratic Party in November. Business is not hated in this country. It doesn't need to be loved, but something in between. Maybe everyone would have done better. Maybe that's the put pay when it comes to business, the White House and the closing stock prices of this administration. Rizwan in Texas. Rizwan, hello.

[Caller]

Jim Booyah from Sugarland, Texas. Thank you and your team for help us out. They're good here. I bought some share below 90 last year. Stock went up to 118 and pulled back. Did I buy more? Hold or sell? And if you can, invite CEO in your show, ticker symbol B is Disney.

[Jim Cramer]

I turned to Jeff Marks. Today was at 106. I said, when should we buy back that stock that we sold much higher. I think you got a great price today. I think Disney is a remarkable company and people are selling it because of the fires in Los Angeles. I feel horrible what's happening in Los Angeles, but I do not think the franchise of Disney is going to be down very much for long. Very much. Eric in Michigan. Eric.

[Caller]

Jim, I love the show.

[Jim Cramer]

Thank you.

[Caller]

Jim, you remember those commercial from the 2009 when it says, When EF Hutton talks, people listen?

[Jim Cramer]

Of course.

[Caller]

So that's Jim Cramer. When Jim Cramer talks, I listen. Having said that, I bought Palantir 8,000 shares of Palantir back in the summer at $30 a share. I took your advice, I listened, and I sold 3,000 shares at $80. So now my question to you is, what do I do with these 5,000 shares? Do I sit on them? Can this.

[Jim Cramer]

No, no, you hold it. You hold it. And when it crops back down, you buy back the stock that you sold. Because this company is a winner. They have really smart people and a lot of good contracts. It's the best data analysis company in the world. Palantir. Trey in Texas. Trey.

[Caller]

Jim, I stopped shopping with my wife years ago after she told me it was, quote, tacky to ask the price of something. I tell you what, I wish she'd be a bit more tacky herself sometimes. Today she came home with a pair of heinous Valentino sandals last worn by Brad Pitt in the movie Troy. Evidently, the commission sales associate told her she just had to get them. Jim, the consumer is strong. And in our household, the consumer's husband is barely hanging on. Should I put what little I have left behind? Shopping name VF Corp.

[Jim Cramer]

I would bet the house of VF Corp. Because the way that your marriage is going, it's the only thing you could save it. I think the stock goes higher. All right. Stocks performed well during the Biden administration's tenure, at least in the aggregate. But was it in spite of his policies? Business doesn't have to be loved. But maybe in the next administration it won't be quite as heated. Well, made money today. I'm back on the east coast, but still lots to unpack from this year's JP Morgan Health Care Conference. I'm bringing you my sit down with biohaven CEO as he breaks down the company's work with new technology. Plus, where do regional banks stand in this department? I'm checking in with First Horizons top brass fresh off the coverage report and later, Biden just issued an 11th hour executive order aimed at strengthening US cybersecurity. I sit down with Opticeo to find out what the heck that means, so stay with Kramer.

[Narrator/Commercial Speaker]

Don't miss a second of Mad Money. Follow at Jim Cramer on X. Have a question? Tweet Kramer. Hashtag MadMoney Dimensions. Send Jim an email to madmoneynbc.com or give us a call at 1-800-743-CNBC. Miss something? Head to madmoney.cnbc.com the 150 billion dollar pet industry is booming as people absolutely love their dogs. If you're looking for a solid investment, Dogtopia is the name to know. With 300 locations across North America, it's the largest, leading and fastest growing pet franchise offering a recurring revenue membership mod. Dogtopia offers safe, open play, dog daycare, boarding and spa services. Want a recession resistant franchise? Check out Dogtopia because every dog and dog parent deserve it. Go to dogtopia.com to learn more.

Every day, thousands of Comcast engineers and technologists create connectivity solutions that change the way we work, live and play. Like Kunle, a Comcast engineer who is focused on revolutionizing the in home Wi Fi experience today and for the next generation. Kunle builds powerful Xfinity WI Fi devices that deliver a fast, reliable connection with capacity to connect hundreds of high bandwidth devices at once and next level latency for the applications of the future like augmented and virtual reality and cloud gaming. Learn [e-mail] wi fi when you're hiring.

The best way to search for a candidate isn't to search at all. Don't search Match with Indeed. Indeed is your matching and hiring platform with over 350 million global monthly visitors, according to Indeed Data and a matching engine that helps you find quality candidates fast. Use Indeed for scheduling, screening and messaging to connect with candidates faster. Plus 93% of employers agree Indeed delivers the highest quality matches compared to other job sites, according to a recent Indeed survey. Leveraging over 14040 million qualifications and preferences every day, Indeed's matching engine is constantly learning from your preferences. Join more than three and a half million businesses worldwide that use Indeed. Listeners of this show will get a $75 sponsored job credit. To get your jobs more visibility@ Indeed.com madmoney just go to Indeed.com madmoney right now and support this show by saying you Heard about Indeed on this podcast. Indeed.com madmoney Terms and conditions apply. Need to hire you need Indeed.

[Jim Cramer]

A little over two years ago, Biohaven sold his key migraine drug to Pfizer for $11.6 billion. Along with everything else, the same class of drug. I used to talk about this one all the time.

[Dr. Vlad Schor]

Right.

[Jim Cramer]

Because the migraine drug Nertek ODT was a game changer for me. Took one this morning. But Biohaven is not some one hit wonder. The rest of the company stuck around renaming itself Biohaven Ltd. And while no longer has Nerdtech, it's got some exciting stuff in the pipeline now that includes drugs in late stage clinical trials for ocd, epilepsy and bipolar disorder, along with early stages treatments for obesity and oncology. In full disclosure, I have a deal with Biohaven to develop a drug that has not yet been announced. I don't know if it'll even pass muster, but I have to disclose it because I play with an open hand. So can lightning strike twice here? Earlier this week we had a chance to catch up with Dr. Vlad Schor. She's the chairman and CEO of Biohaven at the JP Morgan Health Care Conference. Take a look. Vlad, you're going after the toughest. A lot of people go after the easiest, but you're also going after some big ones. This new portfolio of yours is very exciting. Why don't you go over some of the really exciting things you've got.

[Dr. Vlad Schor]

Thanks a lot, Tim. And you know, it's exciting to be here to kick off 2025 and to talk about these new advances. It's only been two years since our spinoff from the Pfizer deal and we have 10 investigational drugs across six therapeutic areas. And we're going after some of the hardest to treat brain disorders. This year we're going to have readouts on bipolar, main mania, depression, ocd, as well as a number of other.

[Jim Cramer]

These have been tried before. Mania's been tried, OCD has been tried, everybody fails. Why do you think that you've got something special, Jim?

[Dr. Vlad Schor]

We're looking at some innovative approaches, new mechanisms that no one's ever explored today. And we have to do that for patients because when you look at our older drugs are plagued with side effects and they're indirectly hitting these disease and frankly, they're not good enough for patients. The new mania medicine that we're looking at hits a novel ion channel called KV7. And we think if you target this, you lower the hyperexcitability of neurons and you're able to treat mania without all the side effects of those older meds, the tardive dyskinesia, the brain bleeds, the metabolic syndrome, we have to move past those.

[Jim Cramer]

Some people might think that mania is a good thing. You know the truth.

[Dr. Vlad Schor]

That's right. Mania is a very disabling thing. All of us in our life experience times where we're exhilarated and we're happy. But when you have mania that persists and it's hyperactive for every moment of your day, it's disabling and you have to bring forward better treatments. It is true that sometimes you get creativity and other things that go along with the mania. But we want to temper down the manic symptoms and the hyper excitability so people can be more functional.

[Jim Cramer]

Now you're into a precision immunology and I think that could be gigantic. Even though it sounds like, well, precision is one or two. No, these are very large markets you're tackling.

[Dr. Vlad Schor]

These are big markets. And when you look at what's been going on in oncology, where precision oncology has changed the field, with a new technology that we have, we think we can actually usher in a true precision immunology. This science comes to us from Yale University. We have a.

[Jim Cramer]

Where you sometimes. That's right, be a full time. And now you've got a lot of things on your plate, but you still teach.

[Dr. Vlad Schor]

Exactly. That's right. And we keep those good relationships because you have to be close to the cutting edge science. And we license this cutting edge science from Yale which allows you to harness your own liver to remove proteins from your body that are causing disease. We call these trap degraders or targeted removals of aberrant proteins. And we can go in and identify in your bloodstream the disease causing pathogen and redirect it to your liver. And your own liver removes it without hitting any other aspect of the immune.

[Jim Cramer]

Is anyone else doing that?

[Dr. Vlad Schor]

We're the only ones who have this technology. Other people, you know what they're doing in immunology? They're trying to target B cells. And when you target B cells you actually then degrade all the normal healthy immune functioning of antibodies like IgA IgE, and then they're indirectly trying to lower that disease causing pathogen. We don't think that's the best way to go. You need your healthy immune functioning. So we use our trap degraders to just pluck out the disease causing pathogen. And at the JP Morgan conference we presented some new human data showing that in IgA nephropathy which is a kidney disease. We can actually just remove renal.

[Jim Cramer]

Yes, renal's pretty amazing. It mystifies people. Tell us about it.

[Dr. Vlad Schor]

Sure. So in renal disease, there's something called IgA nephropathy. And what happens is you have this aberrant protein that causes complexes in your kidneys and stops your kidney from functioning. Everyone else is trying to indirectly get at this protein. We can tag it, send it to the liver, have it removed. And we think this could be a potential cure for this disease.

[Jim Cramer]

Now, we've been speaking with David Rickson, you know, man of the hour, the GOP one. I don't. People realize that muscle goes away, so you may make someone weigh less, but without muscle they can fall. And that's pretty much, you know, we know that that's very disabling for elderly people in particular. You working on something for muscle?

[Dr. Vlad Schor]

We are. And so what we've seen from the GLP is that David, Rickson, Lilly and others have kind of pioneered in this area, is that if you decrease fat, you can have profound effects on your overall health. We know that, but however, we think that you should be decreasing fat without losing muscle. Because you know what happens when you lose muscle. You lose bone density. And when you lose bone density, you can have fractures and other things can occur. And as we all age, we actually lose muscle mass about 10% per year from age 30 onward. Our approach increases muscle, decreases fat and increases bone density. So we think that could be a potential game changer.

[Jim Cramer]

One last one that no one's tackled at all, of course, you go epilepsy.

[Dr. Vlad Schor]

Yes.

[Jim Cramer]

Okay, so we all know epilepsy wrecks people's lives. They're afraid to admit it. They can't lead a normal life if they, if people find out that's they lose their job. Worse, of course. And you're after this one, which no one has had any lockdown.

[Dr. Vlad Schor]

This is another area that needs modernization. Right. Because we do have some therapies that obviously will decrease the number of seizures, but they're plagued with these chronicles side effects. People have cognitive impairment, sedation, difficulty, you know, operating machinery and other things, driving. So we're bringing that same KB7 ion channel activator that we're looking at mania, the same hyper side ability that we decrease there, we think could be a treatment for epilepsy without that baggage and side effects. And patients remember, just like our migraine drug where neurotech odt the migraine went away and people didn't have other baggage and side effects. That's what we want to bring to epilepsy where your seizures can be controlled without all the baggage of the side effects.

[Jim Cramer]

I do want to thank you. Of course you sold that drug to Pfizer for huge amount. When it looks like it's going to rain, I know what I take as soon as I get up. I used have to wait for it to happen and then we got approval taken ahead of time. Thank you from the American Migraine Foundation. Everything you do. Vlad Chorus is the Chairman CEO of Biohaven. Wow. Great to have you.

[Dr. Vlad Schor]

Thank you.

[Narrator/Commercial Speaker]

Coming up, will 2025 be a strong year for the regional banks? Kramer's catching up with the CEO of First Horizon after their earnings Next the $150 billion pet industry is booming as people absolutely love their dogs. If you're looking for a solid investment, Dogtopia is the name to know. With 300 locations across North America, it's the largest, leading and fastest growing pet franchise offering a recurring revenue membership model. Dogtopia offers safe, open play, dog daycare, boarding and spa services. Want a recession resistant franchise? Check out Dogtopia because every dog and dog parent deserve it. Go to dogtopia.com to learn more. With Sling, you get all your favorite news programs for just $45.99 a month. What if I only watch news about whether or not I can afford a boat? $45.99 a month? What about news about how I lost money on the stock market then made money on the stock market? Still $45.99. What about news I only watch so.

I have something to make small talk.

About in uncomfortable um, did you know.

[Jim Cramer]

Police captured five runaway zebras in Washington yesterday?

[Narrator/Commercial Speaker]

Well played. Get all your favorite news programs for the best price. Sling lets you do that. Visit sling.comnews to see your offer.

[Jim Cramer]

We're a couple days into the bank portion of earnings season and we're already hearing from some of our favorite regions like First Horizon, which has grown from Tennessee to become a heavy hitter across the entire Southeast. With cut report this morning, the numbers weren't much of a needle mover. Small revenue miss paired with a 4 cent earnings beat. Please keep in mind that this stock rallied 42% in 2024. It's up another 5.8% year to date so it was coming in hot. Plus when you check under the hood, there was a lot to like your strong credit quality metrics, encouraging commentary about the state of consumer they're doing smart things with the bond portfolio and paying off expensive brokerage CDs that hurt earnings in the pasture. But don't take it from me. Earlier today we got a chance to speak with Brian Jordan. He's the chairman and CEO of First Horizon. Check it out. So, Brian, I read your excellent numbers and I want to know whether your area and your bank has kind of caught the optimism that others have caught since the election.

[Brian Jordan]

Yes, I'd say we certainly have. Our footprint is, is really braming with optimism at this point. We've got a lot of borrowers that are starting to build loan pipeline, loan demand. The economy is doing well and I think we're going to see an uplift here in the early part of 2025.

[Jim Cramer]

Well, I noticed that your charge offs are way down and also commercial real estate. You say that people are ready now. This is so opposite of what we thought could happen at this point.

[Brian Jordan]

Yeah, our charge offs have been very contained. We feel good about our credit performance and year over year we're down about 10 basis points. So that really goes the quality of underwriting. We're seeing still very strong performance in Cree and as I said on our conference call earlier today, we are seeing some commercial real estate developers who are starting to lean a little bit forward at this point. We haven't seen any projects started, but we're seeing signs that people are ready to move forward. And I think that's a reflection of the economy. It's a reflection that we might be adjusting to interest rates as they are today. But all in all, I think it's a very good thing.

[Jim Cramer]

You did say using a prospect of a lot of rate cuts. But then at the same time, you recognize that when they cut the rates last time, long term rates went up and they were actually hurting growth. So what's going to happen in your view about rates?

[Brian Jordan]

I think rates are not likely to go down very much this year. I don't buy the forward curve. We use three cuts in 2025. I'm, I'm a little more cautious than that. I don't think that we'll get one, maybe two cuts over the course of the year. If the economy holds up. You see job growth remain strong. You see inflation which is still running a bit higher than the Fed would like. I think you'll see rates stay in this area. I don't think they're going to go up, but I don't think they're going to go down as much as the market might be optimistically hoping for.

[Jim Cramer]

I'm with you on that now. I noticed some really terrific things you did. You reshuffled the bond portfolio. You got rid of the low rate, you got a higher rate. I also seem to think that you got rid of the so called hot money that goes all over the country which is empty calories doesn't help. So you're in a position with your balance sheet to really be very strong to do work.

[Brian Jordan]

Yep, I agree with you. We did I think a very nice job of repositioning the bond portfolio during the quarter. We sold $1 billion billion 2 in securities from a 1:9 yield and reinvested at a 5 plus percent yield and we got a shorter duration. So I think that will serve us well. And as you suggested we did a lot of work around deposits deposit cost and we reduced very significantly our wholesale fundings over the course of the quarter. So our wholesale deposit base. So we should be very well positioned for a margin that is steady to maybe slightly improving this quarter. But it's I think a balance sheet that will perform very very well notwithstanding what direction the rate curve might take.

[Jim Cramer]

Yeah, and that's exactly what we want from stocks that have been as strong as yours or continue I think be strong. Now a couple of quarters ago you talked about the idea of moving to some of these areas and there was a scrum. People were coming in. You had to spend a lot of money on marketing. I noticed that that's it said marketing expenses related to new bank accounts shifted to other non interest expense for customer incentives. It sounds like that that war is over. You said it would end and you said that your, your franchise would, would be, will come out on top. Obviously those numbers indicate that you have.

[Brian Jordan]

Yeah, I think we're seeing that marketing line come down because there has been a little bit of slowdown in the competitive environment. And I think our investments there have done a very good job of positioning us very well. We've done a great job retaining existing customers and growing new customer relationships and we will continue to invest in the franchise. But I feel good about the way our footprint is performing today.

[Jim Cramer]

Now you are in the strongest area of the country and it seems like the expansion that you made only just made it stronger. What's your feel about that portion of the country that you kind of own, so to speak?

[Brian Jordan]

Yeah, I think the southern footprint that we represent is going to show phenomenal outperformance vis a vis the US economy over the next several years. I'm very encouraged by the demographic trends that we see in the footprint. I think from a policy perspective, whether it's around taxation, right to work and the ability to grow businesses, you will continue to see businesses Relocating to the southern footprint. I think you will continue to see the economy growing at a faster rate and I think that's good for our customers, it's good for our communities and we'll see our shareholders benefit from that as well.

[Jim Cramer]

One last question. I've spoken to a lot of bankers in the last 24 actually I've spoken to every bank in the last 24 hours and something that stunned me was there had been very harsh regulatory tone that the regulators really came in much more heavy handed than a lot of banks thought. And if that is, if that changes and we get more transparency to different rules, that it really will free up a lot of capital to invest. Do you feel that that could happen?

[Brian Jordan]

Yeah, I think you'll see a shift maybe in supervision but I think clearly in regulation you will see that some of the more onerous aspects of the proposals out there will be rethought. I'll give you an example as it relates to us. The proposal today, crossing $100 billion indicates that you would have to raise 6% of risk weighted assets and total loss absorbing capital TLAC. Not that that's necessarily a bad thing but it's very costly and in our case that's a significant amount of debt that we don't have a use today for. And so I think as we go through this I'm hopeful that regulation will continue to be appropriately tailored for size and systemic risk of organizations. And a First Horizon is nowhere near as risky as a JP Morgan or a Bank of America and I think the regulation is more likely to reflect that.

[Jim Cramer]

Well, I think that that's what's necessary, especially in an area that is strong as yours. We want growth, growth is good and you give it to us. Brian Jordan, Chairman presidency of First Horizon with another great quarter. Hey Brian, thank you always for coming on the show and explaining.

[Brian Jordan]

Thank you for having me.

[Jim Cramer]

All right, back into the break.

[Narrator/Commercial Speaker]

Coming up, a Biden executive order aims to strengthen U.S. cybersecurity. Cramer sits down with a leading player in the space to find out what it means for the industry next.

[Jim Cramer]

All right, what's next for the cybersecurity space? I think the demand for the software isn't going away anytime soon because companies can't afford to let hackers tear apart their businesses. However, a lot of corporate customers are trying to to find one stop shop situations with larger players in the group. But what about the small to medium sized players like Octo, one of the leading companies in this identity verification space? Well over a month ago these guys report A real strong quarter. Stocks basically flat. What's it going to take to get this one running? And can we get some information about what is going on with this administration and the things that they're saying these days? Let's check out with topic and he's the co founder and CEO of Okta. He had a better reading the situation. Welcome back to Bear Money.

[Todd McKinnon]

Thanks Jim. It's great to be here.

[Jim Cramer]

You know Todd, you must be up late at night looking at all the things that the Biden administration does at the last minute. 1Today Biden administration launches cybersecurity executive order imposing new security standards for companies to do business with the US Government and the require software companies to demonstrate the security of their development process. Don't they need OCTA to try to figure out what the security is?

[Todd McKinnon]

Well, I think what you're seeing with the Biden administration is consistent over the last four years which is they understand that identity and having great identity verification and great identity security is absolutely critical for the functioning of the government and the effectiveness of the government. And we've had big parts of the federal government from the Department of Defense to large civilian agencies invest in Okta and I think we'll see that continue under the Trump administration. Everyone knows that the stakes are high and we have to defend all these resources and identity is a way to do that. So, so we're, we're happy to, to provide that service to the government.

[Jim Cramer]

Is there a way to stop China? I mean look, they got into the, into the agency that actually talks about many on foreign investment cfius which may be key in the tick tock decision. And the tick tock decision which probably comes down tomorrow from Justice Roberts, is at the heart of our relations with China.

[Todd McKinnon]

Well, the stakes are high as you mentioned in that specific example. And what we see in the industry is that of, of all the security breaches, 80% of them have to do with some kind of compromised identity. As you're talking about, the recent breach at treasury was a access token, an identity access token that was stolen and misused. And we're really trying to lead the fight against these identity based attacks. And if we can help solve these identity based attacks across the entire technology industry, we can get to the root cause of 80% of security breaches which is a huge, huge progress to make. When the stakes are so high, information is so valuable, everyone is trying to make sure they protect it and defend it. And you know, one of the reasons we're positioned well in the market is because we have the leading Independent, neutral identity platform that can help them do just that.

[Jim Cramer]

Well, I thought of you yesterday. I wanted to get on my WI Fi because I'm flying back from San Francisco and what do they want? The last four numbers of my Social Security number. Now, isn't that the way it's done for. How can something that's been done for 100 years still stand up under any scrutiny?

[Todd McKinnon]

Well, these systems, one of the core challenges is these systems need to be better integrated. If the system that was providing airplane WI fi knew who you were and could tell by your biometrics or your another kind of indication on your device, they wouldn't need to ask you this information. Since these systems aren't integrated, the developers of these systems have to resort to really, you know, kind of bad options like asking you for your frequent flyer number and asking you for the last four of your social or you know, God forbid, ask you for a password that's been reused. This is the bad result of when things are integrated and that's why in this business integration is so important.

[Jim Cramer]

Now, how many of the big companies are pulling the trigger up? For instance, last time you said to us on the show when you reported that great quarter organizations are still scrutinizing budgets and rationalizing the software spending, maybe with a sense of new optimism. A lot of people are talking about that after the election. Has some spending gotten a little more robust?

[Todd McKinnon]

This is what I'm seeing and this is in, I would say dozens of conversations over the last couple of months. Companies are being prudent with their spending, but that's leading them to pick trusted partners and then consolidate categories of technology on those partners. I was in a meeting earlier this week where a customer of Okta has told me that they have 40 different identity vendors, that now that they're working with us, they're going to consolidate down to one identity vendor. So people have this, this concept of consolidation and platformization, which is definitely a trend. But what we're saying is that people are going to a one stop shop for identity and they want to go to a one stop shop for identity that is neutral and independent. So it's not like they want to tie up their identity with their collaboration software, if they're or their cloud infrastructure. They want that consolidation on the identity layer so then they can choose and have the freedom and flexibility to choose the best technologies around that.

[Jim Cramer]

Now look, half, I think that the federal government is woefully behind, which is why I know when I hear this, I mean courage. But you said half of the 10 biggest deals you did last quarter were with the US vertical. Now will that change, you think, when, when a president like Trump comes in?

[Todd McKinnon]

I think that it's kind of apolitical. I mean, I mean, we want to defend our systems, we want to protect our information. It makes. One of the big things that the Trump administration talked about is efficiency. So one of the ways you can be more efficient is have more modern technology systems that are easier to use and get the business results and the government results faster. And that means upgrading cyber, that means upgrading systems, and that means having the best information technology. And that's always good for the leading independent neutral identity company to play a role in that.

[Jim Cramer]

Well, how can these big companies not realize that identity is often at the heart of being hacked and instead rely on a one stop shop, say a Microsoft? We know that Microsoft, good company, we've had them on. But I mean, they're not. Their core competency is not cybersecurity.

[Todd McKinnon]

Well, I think that what's really changed in the last five years is that the debate about how important identity is, that debate's over. People know in the industry and people that are trying to have robust cyber defenses know that you have to have a great identity strategy. Now the thing we spend a lot of time talking to customers about and talking to prospects about is this critical architectural decision they need to make to choose an independent, neutral leader and making sure they understand that if you choose identity as part of another platform, whether it's infrastructure or collaboration, you're going to be locked into that platform. And that's not good for your business, that's not good for your government agency. That lack of choice is going to lead the technology strategy of your organization in a certain way, which may not be flexible or may not be robust. Like everyone wants to do AI and everyone wants to have the most robust set of AI agents to make their organization more productive. If your identity is coupled into a certain stack, how are you going to choose the best AI agent stack? You're going to be kind of railroaded into, into a previous choice you made four or five years ago when the technology is changing so fast and who knows, going to, who's going to have the best AI agent framework today? That's a critical technology. You need to have the choice to choose and secure. And by the way, if you're going to secure your agent stack, you need to have robust identity and robust security. So it's one of the reasons why the future is so bright for Okta.

[Jim Cramer]

Doesn't the agent need it too. I mean, why can't you hack an agent? Make it.

[Todd McKinnon]

Because that's the big, that's the secret about agents. Everyone's very, it's very, very exciting technology. But Jim, no one's figured out how to secure them. The frameworks that are out there now, basically, if you think about the agent as a, as a person, it's the equivalent of the agent has a bunch of passwords written on sticky notes on the virtual monitor. That's how the security is done. And that's not going to work. We need better systems and protocols to make sure that those agents only have access to the right thing so they can work on your behalf only when they're trusted. And they do it in a way that it's not going to be hacked and it's not going to let your passwords get leaked all over the Internet. And so that's what's at stake there. So like, like many technology advances, you need the base technology, but you also need the supporting technology. And identity security is a critical, critical supporting technology for our agent future.

[Jim Cramer]

I hope that the Fortune 500 CEOs who watch the show call you because I don't like the fact that they don't seem to understand how, how high the stakes are and how old their technology stack might be. I want to thank Todd McKinney, chair and CEO of Okta always. Ty, good to have you on the show. Thanks for having me back in.

[Narrator/Commercial Speaker]

Coming up, Kramer takes your calls. And the sky's the limit. It's a fast fire lightning round.

[Jim Cramer]

Next, it is time to shout to the lightroom characters. Don't miss a rapper. Close. You said the soccer turtle, but myself has just been real clear. I don't know the chorus stock question. My step is whether you play the sound and then the lightning round is over. Are you ready, Ski daddy? Tell me the lightning round. Crazy. We're off. We'll start with Aaron in Rhode Island.

[Caller]

Aaron, Mr. Kramer, how are we doing.

[Jim Cramer]

Out of you partner, what's happening? All right, so I bought this stock.

[Caller]

At a $100 a share. It's now sitting at around $220 a share and I wanted your professional opinion on how much higher we could see it going. Company name Amazon.

[Jim Cramer]

Amazon. I'll tell you, this is a multi year move. We're not going to look at it on a quarter to quarter basis. I think it'll be higher long term. I've been behind it now for 20 years. I'm not changing my view. Let's go to Bruce in California. Bruce.

[Caller]

Hey, Jimmy, Chill. This is Bruce, first time caller from Newport beach in Southern California. And while it was great having coast, it was a rough week with the fires. Jim.

[Jim Cramer]

Yeah, I'm sorry for everybody that's out. Holy cow. I've lived out there and it's just anyway, just horrible. But go ahead. Let's see if we can. Let's do what we do.

[Caller]

Let's do what we do. And you know, the best investment is prayer because it has unlimited returns and lots of people need our prayers. My question today though is about stock alhc Alignment Health Care.

[Jim Cramer]

I do not know Alignment Health Care. I know it's a software company but I'm not going to just say that. Oh, therefore it's good or bad. I'm going to go do the work. I don't know Alignment Health Care, but thank you for the call. Let's go to Ty and Arizona.

[Caller]

Ty, Professor Kramer, how goes?

[Jim Cramer]

It goes fine. How about you?

[Caller]

I'm good, thanks. My girlfriend and I are huge fans of the show. We love watching you on TV and listening to you in the car on Spotify. We always have tons of great information along with a ton of laughs.

[Dr. Vlad Schor]

So thank you, thank you.

[Jim Cramer]

That's what we want. Thank you very much.

[Caller]

Exactly. The company that we're calling about today is Mike Pro Strategy.

[Jim Cramer]

All right, look, it's a super, super hyped up version of bitcoin. If you really love bitcoin, be my guy. I happen to like bitcoin. I'm not in love with it so I don't need to kind of double down which is what they offer. But look, by all means, if you love bitcoin, you've got to really love that stuff. Let's go to John in Ohio. John. Hey Jim, how you doing? Just want to say I'm doing well.

[Caller]

God bless.

[Jim Cramer]

Thank you. Same to you. Same to you.

[Caller]

My heart goes out to those out in California. On a more serious note, it's a shame that you're in good hands with Allstate until your house burns down. But Jim, what are your thoughts on Berkshire Financial as a long term growth stock?

[Jim Cramer]

I think it's a very inexpensive fintech company. They do a lot of execution. They have a lot of data. They're a great market maker. They're right over there. And I think you should buy the stock. It has always been a good buy for as long as I can remember. I go to Wayne in Connecticut.

[Caller]

Wayne, Professor Kramer, thank you for taking my call. Of course, back in August during the great broadening of the Boom, small cap equities, you thought the stock may be poised for growth. So when home sales didn't pop after the Fed cut interest rates and when Trump became president elect making China tariffs more of a potential reality, you suggested that the stock may not be a good purchase at that price point. Seemingly you may consider buying if the share went below $80. What are your thoughts on Best Buy?

[Jim Cramer]

Well, you know what, I've got a, we have a meeting next week for the club and I feel very, very strongly that Best Buy is too cheap down here. It has been a one way ticket to Haiti from 103 all the way down here. Yields 4.5%. I don't want to give up on Best Buy now when unfortunately the Southland is going to have to have a major redo. I don't know why this stock can't even lift for a single day though. Let's go to Charlie in California. Charlie.

[Caller]

Hey Jim, longtime listener. Recently I bought into a stock ftai.

[Narrator/Commercial Speaker]

I caught a little bit of a.

[Jim Cramer]

Bounce from the 99er drop through.

[Narrator/Commercial Speaker]

Did I hold it or just take my profile?

[Jim Cramer]

Aircraft leasing, terrific business. I would hold on to that. It's the opposite. Say the tanker business which everybody wants to be in. And that ladies and gentlemen, conclusion of the Lightning round.

[Narrator/Commercial Speaker]

The Lightning round is sponsored by Charles Schwab. Coming up, let the chips fall. Kramer dissects the current state of the semiconductor space. Next.

[Caller]

Jim Cramer, the die hard of the dollar. Hey Jimmy, love the show.

[Jim Cramer]

My five year old grandson loves to watch your show.

[Caller]

I have to thank you for making us money when it's there to be made. Our world is a better place with.

[Jim Cramer]

You in right now the whole semiconductor industry feels like it's really in flux. That's how I feel after the blowout quarter from Taiwan semi last night and decision by China also last night to investigate low end US chip makers in America for dumping chips in China. It's hard to keep up with old news flow from the semiconductor industry in the last few days here. First the Biden White House made a midnight weekend decision to pick which countries are allowed to buy unlimited amounts of Nvidia's highest, highest end chips and which ones will be restricted. The White House designated 18 countries as key allies that can get unlimited high end chips from Nvidia, the kind used for artificial intelligence. CEO Jensen Huang has traveled around the world urging countries to develop their own sovereign AI. But the administration restricted whole countries to much smaller numbers of high end chips than they would need to pull that off the list seemed totally Arbitrary, Capricious. To me, many of the countries that Chance would have liked to see have sovereign AI. Well, I mean friends like Israel, Mexico, Portugal, Switzerland. They were not on the friends list. I get the US wants to curtail China from getting high end chips, but the idea that Israel might ship chips to China seems a little fanciful. Sure, the Swiss are canny, but I. I mean, come on. Mexico does tranship Chinese steel to our country, but they're a gigantic trading partner. You can't arbitrarily restrict them. That's exactly what the White House did. The whole new regime seems unnecessarily restrictive to me, even as Nvidia has supported every restriction from the Biden administration on selling chips to China. This dictum flies in the face of positive unified initiative to get the rest of the world up to speed in AI without damaging American interests. Remember, Jensen wont doesn't want America hegemony when it comes to generative AI. At the very least, I think it would have been nice if the White House had given Nvidia a heads up here. Then again, who knows if these rules will stick when Trump takes office next week. Then on a much more positive note, there was last night's Taiwan Semi call. A tour de force from the giant foundry company in Taiwan where they played their hand saying they need a huge amount of semiconductor capital equipment, which sent the stocks of Lamb Research and CALA and Applied Materials into the stratosphere today. I thought people would hear this as a clarion call to buy Nvidia despite the government's punitive restrictions. After all, Taiwan Semi is ordering this new equipment precisely. It can meet demand for Nvidia. But nope, the stock is still in the doghouse. Fell hard today, declining almost 2%. Look, I don't know if traders will feel safe buying this one until Biden's out of the White House. Who knows what they'll do next. They got a couple of days. Then today we got Chinese dumping news. But for once, it's not the Chinese dumping goods here. It's the Chinese charging us with dumping lower end chips there. The kinds made by Texas Instruments who sent that stock plummeting more than 5%. The Chinese also accused our government of unfairly supporting its own semiconductor industry through the U.S. chips and science Act. No kidding. China says that that act, quote, violates the fundamental principle of a market economy, end quote. Now they care about dumping. Didn't seem to bother the Chinese Communist Party when they spent decades dumping cheap manufactured goods here and devastated vast swaths of the US economy. As we all know, the CHIPS act is meant to preserve our semiconductor industry and bring home manufacturing that would otherwise happen overseas because without subsidies, it's just too expensive to do here. It was a good plan, but unfortunately our government chose to give Intel 7.86 billion to build new facilities back in November, on top of an $11 billion federal loans. I'm worried about Intel's credit. Maybe the government should be too, but that's not what our understanding of the bridge. Everything else, I think it's all case by case. For the moment, all that's going to work are the semiconductor equipment makers. At least until President Elect Trump comes in and sorts out these export restrictions. What a shame. I thought we really had something going here. Maybe we can salvage it, but maybe we can. I like to say, as always, bull market summer. I promise I find it just for you right here on that Money. I'm Drew Kramer. See you tomorrow.

[Narrator/Commercial Speaker]

All opinions expressed by Jim Cramer on this podcast are solely Kramer's opinions and do not reflect the opinions of CNBC, NBCUniversal or their parent company or affiliates, and may have been previously disseminated by Kramer on television, radio, Internet or another medium. You should not treat any opinion expressed by Jim Cramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion. Kramer's opinions are based upon information he considers reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Mad Money disclaimer, please visit cnbc.com madmoneydisclaimer you worked hard to lay the foundation for your contracting business, and when you're with AMEG's Business Platinum, you can keep building it up with a flexible spending limit that adapts with your business. And since you earn 5 times Membership Rewards points on flights and prepaid hotels booked on amextravel.com, you get even more from on site overseeing that's the powerful backing of American Express. Not all purchases will be approved terms apply. Learn [e-mail] AmExBusiness.